Showing 981 - 1,000 results of 2,473 for search '"osteosarcoma"', query time: 0.12s Refine Results
  1. 981

    3′,4′-Dihydroxyflavonol Modulates the Cell Cycle in Cancer Cells: Implication as a Potential Combination Drug in Osteosarcoma by José Miguel P. Ferreira de Oliveira, Joana Filipa D. Almeida, Maria Martins, Carina Proença, Helena Oliveira, Eduarda Fernandes, Conceição Santos

    Published 2021-07-01
    “…New agents are demanded to increase the therapeutic options for osteosarcoma (OS). Although OS is the most common bone cancer in children and adolescents, it is considered a rare disorder. …”
    Get full text
    Article
  2. 982

    Cisplatin inhibits the proliferation of Saos-2 osteosarcoma cells via the miR-376c/TGFA pathway by Yuan Wang, Yichao Wu, Awei Cai, Chengxiao Ma, Shang Cai, Hao Wang, Yukang Que, Shenglin Xu, Tangbing Xu, Yong Hu

    Published 2021-04-01
    “…In this study, we investigated the mechanism underlying inhibitory effects of cisplatin on growth and proliferation of osteosarcoma cells. Osteosarcoma and normal skeletal muscle tissues were collected from 26 patients by biopsy. …”
    Get full text
    Article
  3. 983
  4. 984

    Prognostic analysis and clinical characteristics of osteosarcoma and Ewing sarcoma of the rib, sternum, and clavicle: a SEER-based study by Fangming He, Zhan Wang, Genlian Chen, Huanxin Lu

    Published 2023-05-01
    “…Objective Osteosarcoma and Ewing sarcoma of the rib, sternum, and clavicle are rare tumor entities, and their clinical features and treatment outcomes have been rarely reported. …”
    Get full text
    Article
  5. 985

    Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma by Weitang Guo, Xin Wang, Bing Lu, Jiaming Yu, Mingxian Xu, Renxuan Huang, Mingzhe Cheng, Meiling Yang, Wei Zhao, Changye Zou

    Published 2023-07-01
    “…Abstract Osteosarcoma (OS) is a common type of bone tumor for which there has been limited therapeutic progress over the past three decades. …”
    Get full text
    Article
  6. 986

    Targeting POLRMT by a first-in-class inhibitor IMT1 inhibits osteosarcoma cell growth in vitro and in vivo by Yang Kong, Xiangrong Li, Huanle Zhang, Bin Fu, Hua-Ye Jiang, Hui-Lin Yang, Jin Dai

    Published 2024-01-01
    “…Abstract Osteosarcoma (OS) is a highly aggressive form of bone cancer that predominantly affects adolescents and young adults. …”
    Get full text
    Article
  7. 987
  8. 988

    Limb sparing in a cat with a humeral osteosarcoma using a customised three-dimensional printed endoprosthesis by Anthony Malak, William CH Parr, Andrew S Levien, Rachel M Basa

    Published 2023-10-01
    “…A histopathological evaluation of the humerus confirmed a diagnosis of osteoblastic osteosarcoma. Limb-sparing surgery was planned with a custom-designed three-dimensional printed endoprosthesis. …”
    Get full text
    Article
  9. 989

    SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma by Wei Wu, Zhenhao Zhang, Doudou Jing, Xin Huang, Dianyun Ren, Zengwu Shao, Zhicai Zhang

    Published 2022-06-01
    “…However, the anticancer effect of SGLT2 inhibitors in osteosarcoma and the specific mechanism are still unclear. …”
    Get full text
    Article
  10. 990
  11. 991

    Clinical model of pulmonary metastasis in patients with osteosarcoma: A new multiple machine learning-based risk prediction by Zhiping Su, Feihong Huang, Chunyue Yin, Yuezhao Yu, Chaojie Yu

    Published 2023-06-01
    “…Methods We collected data from 612 patients with osteosarcoma (OS), and 103 clinical indicators were collected. …”
    Get full text
    Article
  12. 992
  13. 993
  14. 994
  15. 995
  16. 996
  17. 997
  18. 998
  19. 999
  20. 1000